Scoop has an Ethical Paywall
License needed for work use Register

Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search


Greenlab Secures New Zealand’s Ministry For Primary Industries Grant To Accelerate Medicinal Cannabis Industry

Green Relief NZ Limited T/A Greenlab is the recipient of The Ministry for Primary Industries (MPI) Sustainable Food and Fibre Futures (SFFF) grant for its Lincoln University-based innovative Medical Cannabis research programme.

The $1.9 million Greenlab R&D project has been approved for co-funding of 40 % by New Zealand’s MPI contributing nearly $ 760,000 towards the project over the next three years.

Director for Research and Commercialisation at Greenlab and Project Leader Dr Parmjit Randhawa said the project aim is to specifically develop synchronised agronomic and biochemical parameters to establish evidence-based Medicinal Cannabis industry in New Zealand. Currently it is very challenging for licenced commercial growers to produce product of known medical potency. A lack of industry code of practice means a risk of unsellable product because of unmet chemistry and quality standards.

Dr Randhawa said Greenlab has created rigorous research infrastructure where we will test the unknown New Zealand genetics for cannabinoids and terpene profiles. This will form basis for future plant-based medicines. He further said that Greenlab is honoured to receive MPI co-funding that will enhance Greenlab’s R&D profile and make sure that New Zealand licenced growers have access to essential industry knowledge and insights. The output from the research project will also kick start commercial cannabis breeding programme in New Zealand that will improve medical plant varieties.

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

Greenlab’s Australia based Director Rupinder Brar has been very influential in developing the offshore relationship with investors, manufacturers and prescribers. Mr Brar said that the current white label sale of two Greenlab products in Australian market is progressing well and company is on the path to generate close to one million revenue in current fiscal year. Greenlab is also working on introducing two more white label products in Australian market and registering one of these products in New Zealand. The sale of white label products not only provide revenue stream for Greenlab, but also provide vital information on the medicines required by the doctors and needed by the patients which will help Greenlab R&D team to focus on producing optimised novel compounds of therapeutic potential, said Mr Brar.

© Scoop Media

Advertisement - scroll to continue reading
Business Headlines | Sci-Tech Headlines

FMA: MAS To Pay $2.1M Penalty For Making False Representations

Following proceedings brought by the FMA, MAS has been ordered to pay a $2.1M penalty for making false and/or misleading representations to some customers. MAS admitted failing to correctly apply multi-policy discounts and no claims bonus discounts to some customers, failing to correctly apply inflation adjustments on some customer policies, and miscalculating benefit payments.More

IAG: Call On New Government To Prioritise Flood Resilience

The economic toll of our summer of storms continues to mount, with insurance payouts now topping $1B, second only to the Christchurch earthquakes. AMI, State, & NZI have released the latest Wild Weather Tracker, which reveals 51,000 claims for the North Island floods & Cyclone Gabrielle, of which 99% (motor), 97% (contents), and 93% (home) of claims have now been settled. More


Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.